https://www.zonebourse.com/cours/action/PULMATRIX-INC-54548233/actualite/Pulmatrix-annonce-que-le-premier-patient-a-recu-une-dose-dans-le-cadre-de-l-etude-de-phase-2b-sur-42917716/?utm_source=telegram&utm_medium=social&utm_campaign=share